anmelden
AstraZeneca Aktie
140,55
EUR
-0,90
EUR
-0,64
%
140,10
EUR
-0,80
EUR
-0,57
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 220,08 Mrd. EUR
KGV 27,55 Div. Rendite 1,71%WKN 886455
ISIN GB0009895292
Symbol AZN
AI Analyse
Werbung
AstraZeneca Aktie Analyse
| 24.06.16 | AstraZeneca Verkaufen | Independent Research GmbH | |
| 23.06.16 | AstraZeneca buy | Citigroup Corp. | |
| 14.06.16 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 07.06.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 31.05.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 19.05.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 18.05.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 17.05.16 | AstraZeneca buy | UBS AG | |
|
Werbung
|
|||
| 11.05.16 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 09.05.16 | AstraZeneca neutral | Independent Research GmbH | |
| 05.05.16 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.05.16 | AstraZeneca Hold | HSBC | |
| 03.05.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 03.05.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.04.16 | AstraZeneca buy | UBS AG | |
| 26.04.16 | AstraZeneca neutral | Bernstein Research | |
| 21.04.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 18.04.16 | AstraZeneca buy | UBS AG | |
| 15.04.16 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.04.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 11.04.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 07.04.16 | AstraZeneca buy | Société Générale Group S.A. (SG) | |
| 31.03.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 29.03.16 | AstraZeneca buy | UBS AG | |
| 24.03.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 22.03.16 | AstraZeneca Hold | HSBC | |
| 15.03.16 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 09.03.16 | AstraZeneca overweight | Morgan Stanley | |
| 01.03.16 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 26.02.16 | AstraZeneca Outperform | BNP PARIBAS | |
| 22.02.16 | AstraZeneca buy | Jefferies & Company Inc. | |
| 19.02.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 18.02.16 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.02.16 | AstraZeneca buy | UBS AG | |
| 08.02.16 | AstraZeneca Halten | Independent Research GmbH | |
| 08.02.16 | AstraZeneca Hold | HSBC | |
| 05.02.16 | AstraZeneca buy | Deutsche Bank AG | |
| 05.02.16 | AstraZeneca buy | Société Générale Group S.A. (SG) | |
| 05.02.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 05.02.16 | AstraZeneca buy | UBS AG | |
| 05.02.16 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 04.02.16 | AstraZeneca Hold | S&P Capital IQ | |
| 01.02.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 19.01.16 | AstraZeneca Equal weight | Barclays Capital | |
| 18.01.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 07.01.16 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 05.01.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 04.01.16 | AstraZeneca buy | HSBC | |
| 18.12.15 | AstraZeneca overweight | Morgan Stanley | |
| 18.12.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
Werbung
Werbung
